DOCS Stock Overview
Designs, develops, procures, markets, sells, and distributes footwear under the Dr. More details
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
Dr. Martens plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£0.59 |
| 52 Week High | UK£1.20 |
| 52 Week Low | UK£0.49 |
| Beta | 0.093 |
| 11 Month Change | 5.97% |
| 3 Month Change | -18.00% |
| 1 Year Change | -49.44% |
| 33 Year Change | -85.33% |
| 5 Year Change | n/a |
| Change since IPO | -86.99% |
Recent News & Updates
Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21
Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Recent updates
Benign Growth For Dr. Martens plc (LON:DOCS) Underpins Stock's 30% Plummet
Sep 21Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 45% Undervaluation?
Aug 20Dr. Martens (LON:DOCS) Has Some Way To Go To Become A Multi-Bagger
Jul 20There May Be Some Bright Spots In Dr. Martens' (LON:DOCS) Earnings
Jun 19Dr. Martens plc's (LON:DOCS) Price Is Right But Growth Is Lacking After Shares Rocket 27%
May 21The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Mar 27Dr. Martens (LON:DOCS) Has A Somewhat Strained Balance Sheet
Mar 06Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 57% Above Its Share Price
Feb 08Dr. Martens plc's (LON:DOCS) Business And Shares Still Trailing The Market
Jan 21Dr. Martens' (LON:DOCS) Dividend Will Be £0.0156
Jan 03Dr. Martens (LON:DOCS) Will Pay A Dividend Of £0.0156
Dec 13Dr. Martens (LON:DOCS) Is Very Good At Capital Allocation
Oct 12Calculating The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Sep 13Returns on Capital Paint A Bright Future For Dr. Martens (LON:DOCS)
Jul 12A Look At The Intrinsic Value Of Dr. Martens plc (LON:DOCS)
Jun 02Dr. Martens (LON:DOCS) Is Investing Its Capital With Increasing Efficiency
Feb 25Is There An Opportunity With Dr. Martens plc's (LON:DOCS) 34% Undervaluation?
Dec 17The Trend Of High Returns At Dr. Martens (LON:DOCS) Has Us Very Interested
Oct 02Dr. Martens (LON:DOCS) Knows How To Allocate Capital Effectively
Jul 04Why Investors Shouldn't Be Surprised By Dr. Martens plc's (LON:DOCS) 26% Share Price Surge
Jun 16Are Investors Undervaluing Dr. Martens plc (LON:DOCS) By 27%?
Mar 02Dr. Martens plc's (LON:DOCS) Intrinsic Value Is Potentially 19% Below Its Share Price
Dec 01Shareholder Returns
| DOCS | GB Luxury | GB Market | |
|---|---|---|---|
| 7D | 3.4% | 7.6% | -0.4% |
| 1Y | -49.4% | -32.0% | 5.6% |
Return vs Industry: DOCS underperformed the UK Luxury industry which returned -32% over the past year.
Return vs Market: DOCS underperformed the UK Market which returned 5.6% over the past year.
Price Volatility
| DOCS volatility | |
|---|---|
| DOCS Average Weekly Movement | 7.1% |
| Luxury Industry Average Movement | 7.1% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 10.2% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: DOCS's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: DOCS's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1945 | 2,630 | Kenny Wilson | www.drmartensplc.com |
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear under the Dr. Martens brand name in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company was founded in 1945 and is based in London, the United Kingdom.
Dr. Martens plc Fundamentals Summary
| DOCS fundamental statistics | |
|---|---|
| Market cap | UK£559.55m |
| Earnings (TTM) | UK£69.20m |
| Revenue (TTM) | UK£877.10m |
8.1x
P/E Ratio0.6x
P/S RatioIs DOCS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DOCS income statement (TTM) | |
|---|---|
| Revenue | UK£877.10m |
| Cost of Revenue | UK£301.90m |
| Gross Profit | UK£575.20m |
| Other Expenses | UK£506.00m |
| Earnings | UK£69.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Nov 28, 2024
| Earnings per share (EPS) | 0.072 |
| Gross Margin | 65.58% |
| Net Profit Margin | 7.89% |
| Debt/Equity Ratio | 80.0% |
How did DOCS perform over the long term?
See historical performance and comparison